Large Inflow of Money Witnessed in ABIOMED

ABIOMED (ABMD) : On Thursday, The money flowed into the ABIOMED (ABMD) stock with an uptick to downtick ratio was recorded at 1.42. Transactions worth $0.77 million were done on upticks, confirming the buying interest in the stock. The outflow of money on downticks stood at $0.55 million. The total money flow into the stock was $0.23 million. The investors are using every small weakness in the stock to accumulate it, as can be seen in the $0 million of block transactions on upticks. The total money flow in block trades was $0 million. In terms of price action, ABIOMED (ABMD) traded down $0.19 during the session at $111.25. Compared to the previous days closing, the stock was down only by -0.17%. For the week, the stock is 0.98%, over previous weeks closing.


ABIOMED (ABMD) : The highest short term price target forecast on ABIOMED (ABMD) is $130 and the lowest target price is $55. A total of 8 equity analysts are currently covering the company. The average price of all the analysts is $110 with a standard deviation of $24.99. The stock has recorded a 20-day Moving Average of 9% and the 50-Day Moving Average is 12.9%.

ABIOMED (NASDAQ:ABMD): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $111.96 and $111.14 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $114.50. The buying momentum continued till the end and the stock did not give up its gains. It closed at $113.53, notching a gain of 1.88% for the day. The total traded volume was 592,422 . The stock had closed at $111.44 on the previous day.

Abiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Companys products include Impella 2.5, a percutaneous micro heart pump with an integrated motor and sensors; Impella CP, which is primarily used by either interventional cardiologists to support patients in the catheter lab or by surgeons in the heart surgery suite; Impella 5.0 and Impella LD, a percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute; AB5000, a circulatory support system for the temporary support of acute heart failure patients in profound shock, and Symphony, a minimally invasive implantable cardiac assist device.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.